EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

TUDCA Ameliorates Cognitive Impairment in APP/PS1 Mice by Modulating the Microbiota–Gut–Brain Axis

Minxia Zhan, Hui Chen, Xunzhong Fu, Shijin Tang, Xiaoxian Song, Henghua Li, Liancai Zhu, Bochu Wang

Current Issues in Molecular Biology · 15.01.2026 · 48 (1) · 87

DOI: 10.3390/cimb48010087 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 15.01.2026. Verfasst von Minxia Zhan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bioengineering, Chongqing University, Chongqing 400045, Ch…. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chongqing Municipal Health Commission and Chongqing Science and Technology Bureau.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tauroursodeoxycholic acid (TUDCA), a bile acid conjugate, has been suggested to improve cognition in models of Alzheimer’s disease (AD), although its underlying mechanisms remain unclear. This study aimed to evaluate the effects of TUDCA and its potential pathways in APP/PS1 mice. Behavioral tests, assessments of amyloid-β (Aβ) deposition, neuroinflammation, peripheral inflammatory responses, intestinal barrier integrity, and gut microbiota composition were performed, along with pseudo-sterile mouse experiments and fecal microbiota transplantation (FMT). The expression of genes related to the TLR4/NF-κB/NLRP3 pathway was also examined. TUDCA significantly ameliorated cognitive impairments, reduced Aβ accumulation, and suppressed inflammatory responses in both the central nervous system and peripheral tissues. It improved intestinal barrier function and reshaped gut microbial composition by reducing pro-inflammatory taxa. FMT demonstrated that TUDCA-modulated microbiota contributed to improved learning and memory in AD mice, whereas antibiotic-induced pseudo-sterility indicated that TUDCA also exerted cognitive benefits independent of gut flora. Moreover, TUDCA inhibited the activation of the TLR4/NF-κB/NLRP3 pathway. In conclusion, TUDCA alleviates AD-related cognitive deficits partly through modulation of the microbiota–gut–brain axis while also acting via microbiota-independent mechanisms, supporting its potential as a promising therapeutic strategy for AD.

Schlagwörter

Stichwörter der Autor:innen

Alzheimer’s diseaseTLR4/NF-κB/NLRP3TUDCAinflammationmicrobiota–gut–brain axis

Autor:innen und Institutionen

  • Key Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bioengineering, Chongqing University, Chongqing 400045, China.
  • Chongqing Academy of Chinese Materia Medica, Chongqing 400065, China.
  • School of Chemistry and Chemical Engineering, Chongqing University, Chongqing 400030, China.

Förderung

  • Chongqing Municipal Health Commission and Chongqing Science and Technology Bureau

Zitieren

APA

Zhan, M., Chen, H., Fu, X., Tang, S., Song, X., Li, H., Zhu, L., & Wang, B. (2026). TUDCA Ameliorates Cognitive Impairment in APP/PS1 Mice by Modulating the Microbiota–Gut–Brain Axis. Current Issues in Molecular Biology, 48(1), 87. https://doi.org/10.3390/cimb48010087

Vancouver

Zhan M, Chen H, Fu X, Tang S, Song X, Li H, et al. TUDCA Ameliorates Cognitive Impairment in APP/PS1 Mice by Modulating the Microbiota–Gut–Brain Axis. Current Issues in Molecular Biology. 2026;48(1):87. doi:10.3390/cimb48010087

BibTeX
@article{Zhan2026,
  author = {Zhan, Minxia and Chen, Hui and Fu, Xunzhong and Tang, Shijin and Song, Xiaoxian and Li, Henghua and Zhu, Liancai and Wang, Bochu},
  title = {TUDCA Ameliorates Cognitive Impairment in APP/PS1 Mice by Modulating the Microbiota–Gut–Brain Axis},
  journal = {Current Issues in Molecular Biology},
  year = {2026},
  volume = {48},
  number = {1},
  pages = {87},
  doi = {10.3390/cimb48010087}
}
Kostenlos starten →